Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The moon up close: How the Artemis 2 astronauts are photographing their historic lunar flyby - 2Instructions to Floss Appropriately and Forestall Gum Sickness
- 3Pick Your Favored kind of soup
- 4Auschwitz Committee wants German auction of Holocaust items scrapped
- 5'The best gift ever': Baby is born after the rarest of pregnancies, defying all odds
- Vote In favor of Your Favored Kind Of Vegetable
- Becoming amazing at Arranging Pay Raises
- Forget 'Outer Banks.' These Gen Z-ers just want to watch 'M*A*S*H*' and 'Gilmore Girls.'
- Pick Your Favored kind of soup
- Explainer-What has happened to the damaged spacecraft at China's space station?
- Pilot captures jaw-dropping northern lights show from 36,000 feet (photos)
- These men carry towers of birds through Mexico's streets. They say their tradition is dying out.
- The Response Uncovered: Disentangling the Secrets of the Universe
- Vote in favor of Your #1 Home Exercise Gear: Execution and Comfort Matter
